
@elibaws @conCaramel @johnholowach @AshleyMS43 @heyyitsjanea It’s the potency of the vaccine coupled with cost (requires frequent boosters) that prevents it from being part of routine scheduling like MMR. The risk and virulence is so high you’d think there would be investment to PrEP like HIV.
English

























